ENSEM Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

ENSEM Therapeutics General Information

Description

Developer of precision drugs designed to discover, develop, and commercialize transformative oncology therapies. The company integrates cutting-edge technologies to detect and characterize rare conformational states in drug targets in motion, such states underpinning oncogenic, regulatory, and drug-resistance mechanisms, and offers new opportunities for therapeutic intervention, enabling drug developers to focus on high-value and difficult-to-drug targets.

Contact Information

Website
www.ensemtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 880 Winter Street
  • Suite 1003
  • Waltham, MA 02451
  • United States
+1 (781)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 880 Winter Street
  • Suite 1003
  • Waltham, MA 02451
  • United States
+1 (781)

ENSEM Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ENSEM Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 26-Nov-2025 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 23-Oct-2023 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 07-Apr-2022 $67M $67M Completed Pre-Clinical Trials
To view ENSEM Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ENSEM Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of precision drugs designed to discover, develop, and commercialize transformative oncology therapies. The com
Drug Discovery
Waltham, MA
21 As of 2026

Natick, MA
 

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ENSEM Therapeutics Competitors (53)

One of ENSEM Therapeutics’s 53 competitors is PIC Therapeutics, a Venture Capital-Backed company based in Natick, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PIC Therapeutics Venture Capital-Backed Natick, MA
Kymera Therapeutics Formerly VC-backed Watertown, MA
Genelux Formerly VC-backed Westlake Village, CA
Nurix Therapeutics Formerly VC-backed San Francisco, CA
Allorion Therapeutics Venture Capital-Backed Natick, MA
You’re viewing 5 of 53 competitors. Get the full list »

ENSEM Therapeutics Patents

ENSEM Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026206669-A1 Tetracyclic compounds, and compositions and methods thereof Pending 24-Mar-2025
WO-2026122982-A1 Methods and compositions of tricyclic compounds and derivatives thereof Pending 06-Dec-2024
WO-2026111985-A1 Tetracyclic derivatives, compositions and methods thereof Pending 19-Nov-2024
WO-2026080226-A1 Tricyclic derivatives, compositions and methods thereof Pending 08-Oct-2024
WO-2026072560-A1 Tetracyclic derivatives, compositions and methods thereof Pending 30-Sep-2024 A61P35/00
To view ENSEM Therapeutics’s complete patent history, request access »

ENSEM Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ENSEM Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Seviora Holdings Holding Company Minority
Megarobo VC-Backed Company Minority
Alibaba Group Corporation Minority
CBC Group (Singapore) PE/Buyout Minority
Cenova Capital Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

ENSEM Therapeutics FAQs

  • When was ENSEM Therapeutics founded?

    ENSEM Therapeutics was founded in 2021.

  • Where is ENSEM Therapeutics headquartered?

    ENSEM Therapeutics is headquartered in Waltham, MA.

  • What is the size of ENSEM Therapeutics?

    ENSEM Therapeutics has 21 total employees.

  • What industry is ENSEM Therapeutics in?

    ENSEM Therapeutics’s primary industry is Drug Discovery.

  • Is ENSEM Therapeutics a private or public company?

    ENSEM Therapeutics is a Private company.

  • What is ENSEM Therapeutics’s current revenue?

    The current revenue for ENSEM Therapeutics is .

  • How much funding has ENSEM Therapeutics raised over time?

    ENSEM Therapeutics has raised $77M.

  • Who are ENSEM Therapeutics’s investors?

    Seviora Holdings, Megarobo, Alibaba Group, CBC Group (Singapore), and Cenova Capital are 5 of 7 investors who have invested in ENSEM Therapeutics.

  • Who are ENSEM Therapeutics’s competitors?

    PIC Therapeutics, Kymera Therapeutics, Genelux, Nurix Therapeutics, and Allorion Therapeutics are some of the 53 competitors of ENSEM Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process